38 results about "Molecular Transport" patented technology

Provided herein composition and methods for nanoporous membranes comprising single walled, double walled, or multi-walled carbon nanotubes embedded in a matrix material. Average pore size of the carbon nanotube can be 6 nm or less. These membranes are a robust platform for the study of confined molecular transport, with applications in liquid and gas separations and chemical sensing including desalination, dialysis, and fabric formation.

The present subject matter relates generally to design, synthesis, and characterization of materials with well-defined porous networks of molecular dimensions in which the size and surface energy of the pores can be externally and reversibly controlled to dynamically modulate the adsorption and transport of molecular species.

The invention relates to a sodium alginate-flaky ZIF-8 hybrid composite membrane, and belongs to the field of membrane separation. At first, Zn(NO3)2 and 2-methylimidazole are used as raw materials, and flaky ZIF-8 is prepared in a water phase form through control of synthesis conditions; then, the prepared platy ZIF-8 is dispersed in a sodium alginate water solution to prepare a casting solution, after standing and defoaming, the casting solution spirally coats the surface of a porous polymer ultrafiltration membrane, after drying, the porous polymer ultrafiltration membrane is crosslinked with a calcium chloride solution, and after drying again, the sodium alginate- flaky ZIF-8 hybrid composite membrane is obtained. The hybrid composite membrane can be used for dehydration through pervaporation of an ethanol/water system. Through utilization of the second-dimensional structure and the porous structure of the flaky ZIF-8, the screening effect of the hybrid composite membrane on molecular transport is enhanced, so that the separation performance of the hybrid composite membrane is improved. The preparation process is simple, raw materials are easy to obtain, the structure is controllable, the large-scale preparation and amplification are convenient, and the sodium alginate-flaky ZIF-8 hybrid composite membrane has a good application prospect.

A nanostructured molecular delivery vehicle comprising magnetic materials and configured to receive passenger biomolecules. The application of a an appropriate magnetic field having a gradient orients and drives the vehicle into a biological target, which may comprise cells, cell masses, tissue slices, tissues, etc. Under the control of the magnetic field, these vehicles can penetrate cell membranes. Then, the biomolecules carried by the vehicle can be released into the cells to perform their functions. Using this “nanospearing” technique, unprecendented high transfection efficiency has been achieved in several difficult-to-transfect cells. These include, but are not limited to, Bal 17 cells, ex vivo B cells, primary cultured cortical neurons, etc. This method advances the state of the art, providing an improved technique for the introduction of exogenous molecules to cells, with the clinical applications including, but not being limited to, drug delivery, gene therapy, vaccination, etc.

Preparations of novel molecular transporter compositions and their use for transporting bioactive substances into cells in living animals are disclosed. To afford in vivo delivery, the composition is covalently linked to the bioactive substance and the resultant composite structure is introduced into the subject. The transporter composition includes multiple guanidine moieties on a dendrimeric scaffold having a triazine core.

The invention relates to fragments of Clostridium botulinum HC that can be linked with an entity (e.g., an antigen, a particle, or a radionuclide) and used to deliver the entity across a non-keratinized epithelial membrane of an animal. The fragments are useful, for example, for making vaccines, antidotes, and anti-toxins and in situations in which rapid uptake of an agent by an animal is desired.

The invention provides a device for determining the type of protein in a liquid, the device comprising (a) an immobilized ATP dependent protease based molecular transporter machine configured to guide a protein that is functionalized with labels through a detection area of a detector, (b) said detector, configured to detect a signal as function of the labels of the labelled amino acids, (c) a processor unit, configured to identify from the detector signal a sequence of amino acids of the functionalized protein, wherein the processor unit is further configured to compare the identified sequence of amino acids with the occurrence of such sequence in a database of proteins and to identify the type of protein.

By adding the novel developed modular antigen transporter molecules (MAT molecules) and other instruments related thereto, the immune system of an individual can be effectively modulated in a targeted manner. The MAT molecules contain a translocation module which transports the MAT molecule inside the cell, an active intracellular targeting molecule resulting in intracellular transport of the MAT molecule to the organelles of the cell which are responsible for antigen processing and an antigen module which determines the specificity of the immune response modulated by the MAT molecule. Optionally, other modules such as tag modules or spacer modules can be contained in the MAT molecule. The invention comprises the inventive MAT molecules, antibodies which are produced using said MAT molecules and therapeutic agents and diagnostic reagents which are produced with MAT molecules. The invention also comprises applications containing said MAT molecules, antibodies, therapeutic agents and diagnostic reagents.

Inositol derivatives in accordance with the present invention are effective in significantly enhancing the transportation of various therapeutic molecules across a biological membrane, which may include the plasma membrane, nuclear membrane or blood-brain barrier.

The inventive molecular transporter compound shows significantly high permeability through a biological membrane such as a plasma membrane, nuclear membrane and blood-brain barrier, and accordingly, can be effectively used in delivering various biologically active molecules.

The invention provides a cationic polyvinylamine linear macromolecular transgenic vector, commercially named XELOREXTM RS 1100. The invention provides application of the linear macromolecular transgenic vector as a nucleic acid molecular transport vector. The vector herein provides efficient transfection during cell transfection. The material cost is low; cell toxicity during transfection is low;genetic molecules can be transported to cells effectively and safely. The linear macromolecular transgenic vector has the advantages of high efficiency, low toxicity and low price.

A method and apparatus for simultaneously performing chemical reactions and determining molecular transport dynamics on a plurality of samples such as thin film samples. The apparatus of the present invention is capable of containing multiple samples in individual sample holding positions in a sample holder within a housing and maintaining those holding positions in chemical isolation from each other. Under control of a computerized controller, the apparatus positions the sample holder so that each sample holding position may be positioned adjacent to one or more ports connected to a distribution manifold. The apparatus exposes each sample to one or more fluids in liquid or gas phase, thereby carrying out a chemical reaction and/or determining molecular transport dynamics under controlled temperature and pressure conditions. The sample holding positions may be positioned in an analytical measurement station within the housing so that the resulting chemical compound or mixture may be characterized.

The invention provides a naphthalimide modified dendrimer transgenic carrier which comprises a dendritic polymer skeleton and a naphthalimide containing functional group, wherein the naphthalimide containing functional group is covalently attached to surfaces of dendritic polymers. The invention further provides a preparation method of the dendrimer transgenic carrier and an application of the dendrimer transgenic carrier serving as a nucleic acid molecular transport carrier. A brand new modification method and the functional group are adopted to modify the dendritic polymers, and simple and efficient reaction and high yield are achieved; efficient transfection effect is achieve din the process of cell transfection, simple material production and low cost are achieved, the transfection process has low cytotoxicity, and genetic molecules can be effectively and safety transported into cells; the dendrimer transgenic carrier has the advantages of high efficiency, low toxicity, low price and easiness in synthesis.

Cubic mesoporous silicas having substantially cylindrical morphology may be prepared using a combination of a first structure-directing template, such as tetramethyl ammonium hydroxide; water; a second structure-directing template, such as cetyltrimethylammonium bromide; a morphology-directing template, such as a poloxamer having a weight average molecular weight ranging from 5,000 to 20,000 Daltons; and a silica source; in the substantial absence of an alcohol solvent. The resulting materials may exhibit a three-dimensional channel structure, a length from 3 to 10 micrometers and a width from 300 nanometers to 10 micrometers, resulting in an aspect ratio from 1 to 300. Further characterization may include a surface area from 1300 to 1500 square meters per gram, an average pore diameter from 20 to 26 angstroms, and an average pore volume ranging from 0.7 to 1.1 cubic centimeters per gram. These materials are useful for molecular transport and release applications in a variety of uses, including, for example, membrane separations, metal incorporation, electronic devices, drug delivery, and adsorption.

The invention relates to Variable Domain of Camelid Heavy Chain-only (VHH) molecules which bind TfR and the uses thereof e.g., to transport molecules of pharmaceutical or diagnostic interest into cells and in organs, in pathological conditions including cancer.

An integrated flow source is a limiting factor in numerous microfluidic applications. In addition to precise gradients and controlling molecular transports, a built-in source of stable and accurate flow can enable novel shear stress modulations for long-term cell culturing studies. The Tesla turbine, when used as a pump on the microfluidic regime, produces stable and accurate fluid gradients by utilizing laminar flow between its rotating discs Utilizing a stereolithography based 3D printer, a tesla pump (Ø10 cm) and associated housing capable of driving a microfluidic gradient is provided having a printed rotor surface topology of the pump in order to enhance pumping of biological fluids like blood at elevated viscosities. The surface topology is tuned via 3D pixilation, and this modulation completely recovered the pressure loss between pumping water at 1 cP versus glycerol solution at 3 cP. As a result, increased fluid viscosities, and even Non-Newtonian viscosities, can be used.